Neuren Pharmaceuticals Shares Gain on Upbeat FY Trofinetide Outlook
Neuren Pharmaceuticals shares gained on an upbeat full-year outlook for trofinetide earnings.
Neuren Pharmaceuticals shares gained on an upbeat full-year outlook for trofinetide earnings.